Related Experiment Video
Updated: Apr 1, 2026

Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection
Published on: November 27, 2014
A Survivor of Neonatal Intestinal Mucormycosis
Pragati Aditya Sathe1, Ratnaprabha Kundlikrao Ghodke2, Bhuvaneshwari Mahendra Kandalkar3
1Associate Professor, Department of Pathology, Seth G. S. Medical College and KEM Hospital , Mumbai, India .
Abstract:
Gastrointestinal mucormycosis (GIM) is a rare opportunistic fungal infection. One third of all patients are children and of these, 50% are infants. The most common clinical mimic is necrotizing enterocolitis (NEC). It has to be differentiated from this entity as the treatment is entirely different. High index of suspicion by the clinicians and the pathologists aids in early diagnosis and immediate treatment. If untreated, it has a frequent fatal outcome. Very few survivors of GIM are found in literature. We report a rare case of a surviving neonate of GIM.
Insights
Gastrointestinal mucormycosis (GIM) is a rare fungal infection in infants, often mistaken for necrotizing enterocolitis (NEC). This case highlights a rare infant survivor, emphasizing early diagnosis for effective treatment.
Area of Science:
- Medical Mycology
- Pediatric Infectious Diseases
- Gastroenterology
Background:
- Gastrointestinal mucormycosis (GIM) is a rare, life-threatening opportunistic fungal infection.
- Infants represent a significant portion of pediatric GIM cases, often presenting with symptoms mimicking necrotizing enterocolitis (NEC).
- Accurate differentiation between GIM and NEC is critical due to vastly different treatment protocols.
Observation:
- A neonate presented with clinical signs suggestive of gastrointestinal distress.
- Diagnostic challenges included distinguishing GIM from more common conditions like NEC.
- The neonate received specific antifungal treatment.
Findings:
- The case details a rare instance of a neonate diagnosed with GIM.
- The neonate survived the infection, which typically carries a high mortality rate.
- Successful management required prompt clinical suspicion and pathological confirmation.
Implications:
- This case underscores the importance of a high index of suspicion for GIM in neonates presenting with gastrointestinal symptoms.
- Early diagnosis and appropriate antifungal therapy are crucial for improving outcomes in GIM.
- Further research into GIM in neonates may improve diagnostic strategies and treatment efficacy.
More Related Videos
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
06:51Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
Published on: July 28, 2023
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Development of the Oral Microbiota
Cytomegalovirus Disease